| CAT # | Product Name | Descriptio |
| CPD111306 | 7-bromo-2,4,6-trichloro-8-fluoroquinazoline | |
| CPD113109 | ARS-1323-Alkyne | ARS-1323-alkyne, pactionis sinum (S-IIP) inhibitor |
| CPDP801183 | VVD-214;RO7589831;VVD-133214 | VVD-214 synthetica WRN helicase letalis allostericae inhibitor. |
| CPDP801366 | Inlexisertib;DCC-3116 | DCC-3116 viva voce inhibitor ULK1/2 est. |
| CPDA601378 | Nonylacridine Aureum | |
| CPD112537 | 4H-1,3-Dioxolo[4,5-c]pyrrole-4-acidi carboxylici,... | |
| CPDP801763 | MC3138 | MC3138 est selectivum SIRT5 activator. |
| CPDP801758 | Chk1-IN-6 | Chk1-IN-6 candidatus inhibitor potens, selectivus et oretenus bioavailable CHK1 est. |
| CPD113410 | NDI-101150 | NDI-101150 validus et selectivus inhibitor of HPK1 (progenitor cell kinasi hematopoieticae). |
| CPDA601453 | BMS-986408 | BMS-986408 viva voce efficax est duplicem DGK α/Zeta inhibitorem. |
| CPDA601445 | AZD0780;EX-A6975;laroprovstatum; laroprovstat | PCSK9-IN-12 compositum est heteroaromaticum. PCSK9-IN-12 affinitatem habet pro PCSK9 cum valore Kd< nM CC. PCSK9-IN-12 adhiberi potest ad studium metabolismi cholesteroli. |
| CPDA601447 | PF07328948 | PF-07328948 viva viva voce inhibitor efficax est BDK (cathena ketonis dehydrogenasi rami kinasi) inhibitor. |
| CPD112881 | (1S)-2,2,2-trifluoro-1-methylethyl]hydrazinum hy... | |
| CPD108261 | LOXO-305;LY 3527727; Pirtobrutinib | Pirtobrutinib (LOXO-305) est valde selectivum et non covalens inhibitor-generationis proximus BTK qui varias substitutiones mutationes BTK C481 inhibere potest. |
| CPD115335 | Luxdegalutamide; ARV-766 | Luxdegalutamide (ARV-766) est viva voce hydrolysis dapibus chimaerica iaculis (PROTAC) receptor nisl androgen (AR), qui resistentiam mutatam affinis degradare potest AR. |
| CPDA601356 | iHSP110-33 | |
| CPDP800487 | TNG462 | TNG-462 viva voce inhibitor selectivam PRMT5 efficacem est. |
| CPDP801649 | 1,2,4-Triazolo[4,3-c]pyrimidine-5,8-diamine, N5. | EED ligand 1 diversus et efficax inhibitor est qui scuta EED subunitas methyltransferasis PRC2. |
| CPDM400208 | 6,7-Difluoro-4(3H)-quinazolinone | |
| CPDP801752 | N-(4-quinolinylcarbonyl)Glycine | |
| CPDM400190 | Methyl 5-bromo-2-methyl-3-(trifluoromethyl)benz... | |
| CPDP800126 | IDE397 (GSK-4362676) | |
| CPDP801185 | NST-628 | NST-628 iter est MAPK gel viae hypotheticae cum obice permeabilitatis sanguinis cerebri, quae phosphorylationem et MEK activationem inhibere potest. |
| CPD115153 | NX-2127 | NX-2127 inhibitor viva voce est efficax BTK. |
